ADVERTISEMENT
ADVERTISEMENT
3D illustration of a blue cancer cell secreting tiny blue exosomes. On the right and left, two purple immune cells flank the cancer cell.
An Exosome Protein Sets the Stage for a Cancer Biomarker
Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor detection and therapy.
An Exosome Protein Sets the Stage for a Cancer Biomarker
An Exosome Protein Sets the Stage for a Cancer Biomarker

Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor detection and therapy.

Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor detection and therapy.

Drug Discovery & Development

Tktk
Phage Proteins Help Improve Drug Delivery
Shelby Bradford, PhD | Jan 13, 2025 | 1 min read
Researchers used bacteriophages’ ability to target specific bacteria to develop nanoparticle vehicles for antibiotics.
Abstract blue nautilus shell displaying a characteristic fractal shape
Attacking Cancer Targets with Radiotherapeutics
The Scientist Staff | Jan 8, 2025 | 4 min read
John Babich from Ratio Therapeutics explains how radiopharmaceuticals can be designed to better treat cancer, alone and in combination with immunotherapies.
Green Bio-Rad Logo
Bio-Rad Extends Range of Foresight Pro Prepacked Chromatography Columns for Biotherapeutic Production
Bio-Rad Laboratories | Jan 7, 2025 | 2 min read
Foresight Pro 45 cm ID Column Provides a Convenient and Reliable Solution for Purification of Biomolecules in Downstream Bioprocessing.
Advances in Cancer Therapies and Diagnostics
Advances in Cancer Therapies and Diagnostics
The Scientist Staff | Jan 6, 2025 | 2 min read
Learn about the latest research in cancer biology and translational applications.
An illustration of an orange tau fibril in front of a blue background.
Uncovering the Unexpected: Developing a Novel Anti-Tau Therapy
Charlene Lancaster, PhD | Dec 31, 2024 | 4 min read
Ke Hou generated a compound that prevents tau aggregation in the murine brain, but the potential Alzheimer’s disease therapy also had a surprising property.
Gram-negative, rod-shaped bacteria expressing pili.
Building Bacterial Drug Factories
Aparna Nathan, PhD | Dec 30, 2024 | 3 min read
Drug-manufacturing bacteria can provide a more targeted approach to treat gut diseases.
A man holds his knee and grimaces in pain while sitting in front of a bridge.
A Nanoparticle Approach to Treat Torn Tendons
Aparna Nathan, PhD | Dec 29, 2024 | 4 min read
Alayna Loiselle has found a way to bring therapeutics straight to an injured tendon.
Graphic depicting a tumor being targeted by a drug
Great Anticancer Potential Comes in a Small Package 
Niki Spahich, PhD | Dec 28, 2024 | 4 min read
Jingjing Sun developed a novel, ultra-small nanocarrier that actively targets tumor cells.
A conceptual illustration of scientists evaluating potential kinase inhibitors.
Leveraging Recombinant Kinases for Drug Discovery Research
The Scientist and Sino Biological | Dec 26, 2024 | 3 min read
As kinase dysfunction underlies many pathological conditions, scientists require high-quality active kinases for their therapeutic development programs.
3D conceptual image of antibodies on a blue background.
Improving the Efficiency and Reliability of Fully Human Antibody Drug Development
The Scientist Staff | Dec 16, 2024 | 2 min read
Microfluidic technology enables high-throughput, droplet-based antibody discovery in fully human antibody mice.
Brightfield microscopy image of Aspergillus fumigatus.
The Silent Pandemic of Antifungal Resistance
Danielle Gerhard, PhD | Dec 16, 2024 | 2 min read
As the world grapples with antimicrobial-resistant bacteria, another insidious threat looms large: drug-resistant fungi.
New Frontiers in Vaccine Development
New Frontiers in Vaccine Development
The Scientist Staff | Dec 12, 2024 | 2 min read
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
Evotec logo
Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk
Evotec | Dec 11, 2024 | 3 min read
Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases
Beckman logo
Beckman Coulter Life Sciences Accelerates Drug Discovery with Launch of Cydem VT Automated Clone Screening System
Beckman Coulter Life Sciences | Dec 4, 2024 | 2 min read
High-Throughput Platform Reduces Manual Steps by up to 90%
Scientist at lab bench holding a pipette with a microscope and glassware in the foreground.
Improving Drug Analysis with Supercritical Fluid Chromatography
Shimadzu | Dec 2, 2024 | 1 min read
Researchers easily separate chiral and achiral compounds for drug analysis and purification.
A photo of a 96-well microplate showcasing serial dilutions of purple dye solution.
Achieving Consistency in Serial Dilutions
The Scientist Staff | Dec 2, 2024 | 2 min read
Researchers ensure the success of their serial dilution-based assays by using optimized protocols and advanced liquid handling tools.
An illustration of mRNA molecules.
Probing the Structure of mRNA Molecules
Shimadzu | Nov 25, 2024 | 1 min read
Learn how scientists examine mRNA quality using an easy-to-operate LC-MS system.
Drugging the Undruggable
Drugging the Undruggable
The Scientist Staff | Nov 19, 2024 | 1 min read
Learn how cutting-edge strategies empower researchers to target undruggable proteins.
Takara Bio Logo
Takara Bio launches high-throughput, cost-effective qPCR system to advance clinical research
Takara Bio | Nov 19, 2024 | 2 min read
The SmartChip ND system meets laboratories’ needs for flexibility, scalability, efficiency, and affordability.
ADVERTISEMENT